IDEAS home Printed from https://ideas.repec.org/a/cai/riddbu/ride_243_0325.html
   My bibliography  Save this article

L'accès des pays pauvres aux médicaments et la propriété intellectuelle : quel apport des partenariats multiacteurs ?

Author

Listed:
  • Bruno Boidin
  • Lucie Lesaffre

Abstract

The reinforcement of IPRs protection resulting from the entry into force of the TRIPs agreement has significant consequences on access to medicine in poor countries. This very sensitive issue has provoked vivid debate and a great deal of controversy. Public/private partnership agreements between international organizations active in the health field, such as the WHO, NGOs and pharmaceutical companies are amongst strategies explored in order to overcome the drawbacks of the enhanced protection of IPRs on access to medicine. This article analyzes the efficiency of those partnership agreements with a focus on their potential as well as the challenges they face in ensuring improved access to medicine in poor countries.

Suggested Citation

  • Bruno Boidin & Lucie Lesaffre, 2010. "L'accès des pays pauvres aux médicaments et la propriété intellectuelle : quel apport des partenariats multiacteurs ?," Revue internationale de droit économique, De Boeck Université, vol. 0(3), pages 325-350.
    • Handle: RePEc:cai:riddbu:ride_243_0325
    as

    Download full text from publisher

    File URL: http://www.cairn.info/load_pdf.php?ID_ARTICLE=RIDE_243_0325
    Download Restriction: free
    File URL: http://www.cairn.info/revue-internationale-de-droit-economique-2010-3-page-325.htm
    Download Restriction: free
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Anne Branciard, 2012. "Open and collaborative research and development models : towards "commons" ? [Des modèles de recherche-développement ouverts et collaboratifs dans le domaine pharmaceutique : vers des « c," Post-Print halshs-02566715, HAL.
    2. Anne Branciard, 2013. "DNDi : from open innovation to commons for essential drugs ? [DNDi : de l'innovation ouverte à l'impulsion de communs pour des médicaments essentiels ?]," Post-Print halshs-02566783, HAL.
    3. Boidin, Bruno, 2015. "Économie politique de la santé comme bien public mondial," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cai:riddbu:ride_243_0325. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Jean-Baptiste de Vathaire (email available below). General contact details of provider: https://www.cairn.info/revue-internationale-de-droit-economique.htm .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.